KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Long-Term Debt Repayments (2016 - 2025)

Amgen has reported Long-Term Debt Repayments over the past 15 years, most recently at $1.5 billion for Q3 2025.

  • Quarterly results put Long-Term Debt Repayments at $1.5 billion for Q3 2025, down 31.82% from a year ago — trailing twelve months through Dec 2025 was $5.0 billion (up 38.89% YoY), and the annual figure for FY2025 was $5.0 billion, up 38.89%.
  • Long-Term Debt Repayments for Q3 2025 was $1.5 billion at Amgen, up from $1.0 billion in the prior quarter.
  • Over the last five years, Long-Term Debt Repayments for AMGN hit a ceiling of $4.2 billion in Q4 2021 and a floor of $704.0 million in Q1 2023.
  • Median Long-Term Debt Repayments over the past 4 years was $1.5 billion (2024), compared with a mean of $1.8 billion.
  • Biggest five-year swings in Long-Term Debt Repayments: soared 193.33% in 2024 and later plummeted 31.82% in 2025.
  • Amgen's Long-Term Debt Repayments stood at $4.2 billion in 2021, then tumbled by 81.93% to $750.0 million in 2023, then skyrocketed by 193.33% to $2.2 billion in 2024, then plummeted by 31.82% to $1.5 billion in 2025.
  • The last three reported values for Long-Term Debt Repayments were $1.5 billion (Q3 2025), $1.0 billion (Q2 2025), and $2.5 billion (Q1 2025) per Business Quant data.